from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2189c/-

LFCtreatmentdescriptionclass of inhibitor

0.789

Amikacinug/mL Amikacintranslation

0.543

Cap5-10ug/mL Capreomycintranslation

1.226

Rox10-50 ug/mL Roxithromycintranslation

0.719

SM2-5 ug/mL Streptomycintranslation

-0.140

Tet5-10 ug/mL Tetracyclinetranslation

0.576

Rif0.2-5ug/mL Rifampicintranscription

-0.009

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.389

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.106

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.513

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.403

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.629

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.395

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.803

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.892

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.793

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.664

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.602

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.475

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.728

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.471

KCN5-20 ug/mL Potassium cyaniderespiration

-1.148

NaN30.2-2 mM Sodium aziderespiration

-0.105

Nigericin50 uM Nigericinrespiration

-0.039

TRC10-150 ug/mL Triclosanrespiration

-2.054

TRZ10-25 ug/mL Thioridazinerespiration

2.275

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.848

menadione6-10 ug/mL Menadionerespiration

-0.264

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.166

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.750

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.807

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.004

NRP_1Non-replicating persistence stage 1dosRassociated

0.398

Amp0.2mg/mL AmpicillincellWall

0.059

Cephalexin20-100 ug/mL CephalexincellWall

-0.785

Cerulenin0.32-5 ug/mL CerulenincellWall

1.275

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.457

EMB10-20 ug/mL EthambutolcellWall

0.154

Eta12-40 ug/mL EthionamidecellWall

0.065

INH0.2-0.4 ug/mL IsoniazidcellWall

0.078

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.296

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.212

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.511

BZA0.12 mg/mL BenzamidearomaticAmides

0.480

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.459

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.212

H2O24 mM hydrogen peroxideDNAdamaging

0.049

Levo10 ug/mL LevofloxacinDNAdamaging

-0.391

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.036

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.278

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.533

UVUV-irradiationDNAdamaging

0.240

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.256

Antimycin12.5-50 ug/mL Antimycin A?

-0.588

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.890

PA_110-50 ug/mL Antitubercular compound PA-1?

0.518

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.313

PA8240.2-2 ug/mL PA-824?

-0.495

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.045

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.309

Verapamil50 uM Verapamil?

-0.193

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.641

methoxatin10-20 ug/mL Methoxatin?